Munich, Germany – DERMANOVIS, a physician-led network of dermatology clinics, announced a growth investment from leading, growth-focused investor Summit Partners. The capital supports the expansion of the DERMANOVIS’ integrated platform for medical and aesthetic dermatology across Germany.
Led by physicians and healthcare executives with deep experience building and integrating medical networks, DERMANOVIS unites experienced dermatologists and established clinics with a shared focus on expanding access to specialized high-quality dermatological care.
“Dermatology touches nearly every patient population and demand for specialized care continues to grow, driven by an aging population, rising rates of skin disease and increasing interest in aesthetic and preventative treatments,” said Dr. Daniel Wichels, CEO of DERMANOVIS. “Our goal is to build a leading dermatologic network that supports physician collaboration, facilitates modern practice management and fosters continuous learning and clinical excellence. We believe Summit’s experience supporting physician-led healthcare companies makes them an ideal partner as we work to expand across Germany.”
“We believe DERMANOVIS represents a new approach to dermatologic care in Germany,” said Thomas Tarnowski, Managing Director at Summit Partners. “By supporting an integrated, physician-led network that offers medical and aesthetic expertise, we aim to help expand access to specialized care and strengthen collaboration across practices.”
“Dr. Wichels and the team have broad experience building patient-focused healthcare organizations that emphasize medical quality with integrated clinical and operational practices,” added Jono Pagden, Principal at Summit Partners. “We’re proud to support their vision for a platform that empowers physicians and seeks to deliver great care to patients nationwide.”
Related News
Get the Latest from Summit Partners
Subscribe to our newsletter to stay up to date on our partners, portfolio, and more.
